Deal Benchmarking

At Evaluate, our mission is simple: to help patients gain access to life-saving therapies. Evaluate is a Norstella company, a collection of prominent pharmaceutical solutions providers that have joined forces to offer a full range of consultancy services and solutions. Evaluate provides life sciences clients with the right tools and expertise to navigate complexities at each step of the drug development life cycle, from pipeline to patient. Our offerings include cutting-edge data solutions, consensus forecasts and expert advisory services alongside advanced technologies such as machine learning and predictive analytics.

The “Deal Benchmarking” data product provides a comprehensive dataset for evaluating and benchmarking business deals in the pharmaceutical industry. By combining these tables, users can gain a holistic view of deal-making activities in the pharmaceutical industry and perform detailed benchmarking analyses.

The following sets of data have been included in this listing:

Drugs - Names and Identifiers: This table provides the names and identifiers of various drugs. It can be used to identify specific drugs involved in deals.

Drugs - Classifications: This table categorizes drugs based on their therapeutic class, mechanism of action, etc. It can be used to benchmark deals within specific drug classes.

Drugs - Product Sales: This table provides sales data for various drugs. It can be used to evaluate the financial performance of drugs involved in deals.

Drugs - Profiles: This table provides detailed profiles of various drugs. It can be used to understand the characteristics of drugs involved in deals.

Companies - Profiles: This table provides profiles of various companies. It can be used to understand the characteristics of companies involved in deals.

Drugs - Patents: This table provides information on patents. It can be used to evaluate the intellectual property aspects of product deals.

Deals - M&A: This table provides information on mergers and acquisitions. It can be used to benchmark M&A deals.

Companies - Names and Identifiers: This table provides the names and identifiers of various companies. It can be used to identify specific companies involved in deals.

Companies - Classifications: This table categorizes companies based on their segment, size, etc. It can be used to benchmark deals within specific company categories.

Drugs - USA - NDC: This table provides National Drug Code (NDC) data for drugs in the USA. It can be used to identify specific drugs involved in deals within the USA.

Deals - Licensing, product sales, platforms: This table provides information on licensing deals, product sales, and platform deals. It can be used to benchmark these types of deals.

Deals - VF - Investor profiles: This table provides profiles of investors involved in venture financing (VF). It can be used to understand the characteristics of investors involved in funding rounds.

Indication-level treatment information: This table provides information on treatments at the indication level. It can be used to understand the therapeutic areas covered by drugs involved in deals.

You can use this data to analyze trends, make predictions, and inform your decision-making process in the pharmaceutical industry.

Once you subscribe to this listing, you will have access to all the data tables required.

Workflow:

• Consumer clicks Request button on Evaluate listing<br/>• Evaluate will reach out to the consumer and finalize terms.<br/>• Evaluate shares the data product with the consumer via Snowflake shares.

Additional Information<br/>This data product is updated regularly to ensure that you have the most recent and accurate information. If you have any questions or need further information, please don’t hesitate to contact us.